| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.230 | None | 1.000 | 4 | 0 | 1997 | 2019 | ||||||||
|
CD59 molecule (CD59 blood group) | 0.469 | 0.808 | 0.61 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
C-C motif chemokine receptor 1 | 0.531 | 0.769 | 0.39 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
C-C motif chemokine ligand 3 | 0.460 | 0.885 | 0.35 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2006 | 2011 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.110 | None | 1.000 | 2 | 1 | 2013 | 2015 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
endoplasmic reticulum aminopeptidase 1 | 0.556 | 0.692 | 2.1E-26 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
innate immunity activator | 0.743 | 0.346 | 2.2E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
interleukin 19 | 0.558 | 0.769 | 4.3E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
macrophage migration inhibitory factor | 0.412 | 0.885 | 1.2E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
laccase domain containing 1 | 0.700 | 0.423 | 1.2E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2005 | 2019 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2011 | 2013 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2007 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
transforming growth factor beta 2 | 0.433 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |